Evaluation of some Blood levels of Chronic Kidney Diseases Patients In Wasit Province Iraq
Palabras clave:
Chronic kidney disease, RBC, PCV and Sedimentation rate ESRResumen
Chronic kidney disease (CKD) is a condition of progressive loss of kidney function diagnosed when the estimated glomerular filtration rate (GFR) is less than 60 mL/min/1.73 m2, persisting for three months or longer. Epidemiological updates for 2022 indicate that the current total number of individuals with CKD at stages 1 to 5 worldwide is estimated at 843 million. Risk factors can be identified by studying blood components, where statistically significant differences are found in statistical analysis of some blood parameters (Red blood cells RBC , Hemoglobin Hb, Hematocrit PCV and Sedimentation rate ESR), in addition to decreased production of endogenous Erythropoietin (EPO), a hormone involved in the differentiation and maturation of red blood cells. Other contributing factors have been identified, such as poor bone marrow response to erythropoietin, decreased availability of iron for red blood cell formation, or Vitamin deficiencies (vitamin B12 or folic acid). Furthermore, the kidney is the main regulator. 90 subjects of both genders were collected, including 60 patients and 30 from the control group. The results showed that the level of blood parameters had significant differences compared to the control group at p ≤ (0.05). The studied parameters contribute as indicators of the development of health risks to the body and kidney health in chronic kidney disease patients.
Descargas
Referencias
- Mahajan, C.; Tiwari, V.; Divyaveer, S.S.; Patil, M.R.; Banerjee, A.; Bagur, V. (2020). Spectrum of renal biopsies; a
three-year data from a tertiary care Centre of eastern India. J Nephropharmacol.;9(2):e20–e.
- Dritsas, E. and Trigka, M. (2022). Machine learning techniques for chronic kidney disease risk prediction. Big Data
and Cognitive Computing, 6(3), 98.
- Abdel-Kader, K.(2022). Symptoms with or because of Kidney Failure? Clin. J. Am. Nephrol. 17, 475–477 .
- Kimura, K.; Hosoya, T.; Uchida, S.; Inaba, M.; Makino, H.; Maruyama, S. (2018).Febuxostat therapy for patients with
stage 3 CKD and asymptomatic Hyperuricemia: a randomized trial. Am J Kidney Dis.;72(6):798–810.
- Stauffer, M.E. and Fan, T.(2014). Prevalence of anemia in chronic kidney disease in the United States,9:e84943.
- Mikhail, A.; Brown. C.; Williams, J.A. (2017).Renal association clinical practice guideline on anaemia of chronic
kidney disease. BMC Nephrol.;18:345.
- Yin, P.; Wu, Q.; Shou, L.(2021). Risk factors for anemia in patients with chronic kidney disease: a protocol for
systematic review and meta-analysis. Medicine (Baltim) .100:e273711–3.
- Wong, M.M.Y.; Tu, C.; Li, Y. (2020). Anemia and iron deficiency among chronic kidney disease stages 3-5ND
patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably
treated.;13:613–24.
- Fishbane, S.; Spinowitz, B. (2018).Update on anemia in ESRD and earlier stages of CKD.71:423–35.
- Adera, H.; Hailu, W.; Adane, A.; Tadesse, A.(2019). Prevalence of anemia and its associated factors among
chronic kidney disease patients at university of Gonder hospital, northwest Ethiopia: a hospital-based cross-sectional
study ,12:219–228.
- Poudel, B.; Yadav, B.K.; Jha, B.; Raut, K.B.(2019). Prevalence and association of anemia with CKD: a hospital-based cross-sectional study from Nepal Prevalence and association of anemia with CKD. protein: impact of dialysis
procedures. Artif Organs. 2020;44(6):647–54.
- Kang, E.; Han, M.’ Kim, H. (2017). Baseline general characteristics of the Korean chronic kidney disease: report
from the Korean cohort study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).;32(2):221–230.
- Abdulrahaman, Y.; Osaro, E.; Uko, E. K.;Isaac, I. Z.; Bello, Z.; Liman, H. M. (2013). Packed cell volume,
Reticulocyte count and index among patients with chronic kidney disease in Sokoto, North-western Nigeria. Journal of
Medical and Health Sciences, 2319-9865.
- Buckenmayer, A.; Dahmen, L.; Hoyer, J.; Kamalanabhaiah, S. and Haas, C. S. (2022). Erythrocyte sedimentation
rate in patients with renal insufficiency and renal replacement therapy. Laboratory Medicine, 53(5), 483-487.
- Etim, E. A. (2018). Effect of maintenance hemodialysis on red cell indices and erythrocyte sedimentation rate in northeast Nigeria. Age (years), 50(58), 0-01.
-Ahmed, T. H., & Al-Mousawi, N. H.. Post-Hospitalization, Levels of D-dimer, C-Reactive Protein, Ferritin, And Lactate Dehydrogenase in Recovered COVID-19 Iraqi Patients. Systematic Reviews in Pharmacy, 12.1 2021.
-AL-Rubaie, S. A., AL-Attabi, M. R., & AL-Kinani, A. A.. Study the Inflammatory Biomarkers of Acute Coronary Syndrome Patients in Wasit Province. Indian Journal of Public Health Research & Development, (2019), 10 (10). 2352.0976-0245. DOI: 10.5958/0976-5506.2019.03210.8.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2024 AUTHOR
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato para cualquier propósito, incluso comercialmente.
- Adaptar — remezclar, transformar y construir a partir del material para cualquier propósito, incluso comercialmente.
- La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia
Bajo los siguientes términos:
- Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios . Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
